Balance Sheet Data
Oramed Pharmaceuticals Inc. (ORMP)
$2.22
+0.02 (+0.91%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 30.46 | 32.28 | 39.90 | 94.14 | 155.72 | 73.57 | 76.11 | 78.75 | 81.47 | 84.29 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 1.13 | 1.34 | 0.59 | 2.61 | 2.18 | 1.65 | 1.70 | 1.76 | 1.82 | 1.89 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.01 | -0.02 | -0.08 | -0.38 | -0.50 | -0.20 | -0.21 | -0.22 | -0.22 | -0.23 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.